Response of Authors to Ganju and Dias’ Comments on ‘Inclusion of Placebos and Blinding for Ascending Dose First-In-Human Studies and Other Underpowered Phase 1 Studies Has Not Been Justified and on Balance Is Not Useful’ by D. A. Parasrampuria and L. Z. B
Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.12483
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2015
Authors
Publisher
Wiley